Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saima Hassan

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Biomimetics (Basel, Switzerland)|May 23, 2023
Data Diversity in Convolutional Neural Network Based Ensemble Model for Diabetic RetinopathyInamullah, Saima Hassan, Nabil A Alrajeh, et al.
Translational Oncology|March 7, 2025
Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancerMallory I Frederick, Elicia Fyle, Anna Clouvel, et al.
Molecular Cancer Therapeutics|September 30, 2017
Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast CancerSaima Hassan, Amanda Esch, Tiera Liby, et al.
The American Journal of Pathology|June 6, 2009
The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancerSaima Hassan, Cristiano Ferrario, Uri Saragovi, et al.
British Journal of Cancer|March 21, 2023
Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancerMichèle Beniey, Audrey Hubert, Takrima Haque, et al.
Breast Cancer Research : BCR|March 19, 2013
Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancerMarc-André Déry, Julie Jodoin, Josie Ursini-Siegel, et al.
Breast Cancer Research and Treatment|March 21, 2009
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancersSophie Hamel, Amélie Bouchard, Cristiano Ferrario, et al.
Vaccines|October 27, 2022
Ingraining Polio Vaccine Acceptance through Public Service Advertisements in the Digital Era: The Moderating Role of Misinformation, Disinformation, Fake News, and Religious FatalismQiang Jin, Syed Hassan Raza, Muhammad Yousaf, et al.
International Journal of Cancer|September 11, 2010
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse modelSaima Hassan, Marguerite Buchanan, Kaushar Jahan, et al.
Annals of Surgical Oncology|December 16, 2014
Erratum to: Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit DiseaseSaima Hassan, Teresa M Petrella, Tong Zhang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Biomimetics (Basel, Switzerland)|May 23, 2023
Data Diversity in Convolutional Neural Network Based Ensemble Model for Diabetic RetinopathyInamullah, Saima Hassan, Nabil A Alrajeh, et al.
Translational Oncology|March 7, 2025
Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancerMallory I Frederick, Elicia Fyle, Anna Clouvel, et al.
Molecular Cancer Therapeutics|September 30, 2017
Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast CancerSaima Hassan, Amanda Esch, Tiera Liby, et al.
The American Journal of Pathology|June 6, 2009
The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancerSaima Hassan, Cristiano Ferrario, Uri Saragovi, et al.
British Journal of Cancer|March 21, 2023
Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancerMichèle Beniey, Audrey Hubert, Takrima Haque, et al.
Breast Cancer Research : BCR|March 19, 2013
Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancerMarc-André Déry, Julie Jodoin, Josie Ursini-Siegel, et al.
Breast Cancer Research and Treatment|March 21, 2009
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancersSophie Hamel, Amélie Bouchard, Cristiano Ferrario, et al.
Vaccines|October 27, 2022
Ingraining Polio Vaccine Acceptance through Public Service Advertisements in the Digital Era: The Moderating Role of Misinformation, Disinformation, Fake News, and Religious FatalismQiang Jin, Syed Hassan Raza, Muhammad Yousaf, et al.
International Journal of Cancer|September 11, 2010
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse modelSaima Hassan, Marguerite Buchanan, Kaushar Jahan, et al.
Annals of Surgical Oncology|December 16, 2014
Erratum to: Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit DiseaseSaima Hassan, Teresa M Petrella, Tong Zhang, et al.
Pageof 3